Anavex Life Sciences (AVXL) Gains from Investment Securities (2013 - 2025)
Anavex Life Sciences recorded quarterly Gains from Investment Securities of $8.6 million in Q4 2025, up 331.94% quarter-over-quarter from $2.0 million in Q3 2025, and up 463.33% year-over-year from $1.5 million in Q4 2024.
Anavex Life Sciences' Gains from Investment Securities history runs 13 years deep, the most recent figure standing at $8.6 million for Q4 2025.
- In Q4 2025, Gains from Investment Securities rose 463.33% year-over-year to $8.6 million; the TTM figure through Dec 2025 stood at $8.6 million (up 56.72% YoY), while the FY2025 annual figure was $15.0 million, down 0.51% from the prior year.
- Gains from Investment Securities came in at $8.6 million for Q4 2025 at Anavex Life Sciences, up from $2.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $15.0 million in Q3 2024 to a low of $29167.0 in Q2 2021.
- A 5-year average of $4.8 million and a median of $2.2 million in 2022 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities plunged 98.28% in 2021 and jumped 7470.2% in 2022, its largest moves.
- Anavex Life Sciences' Gains from Investment Securities stood at $2.3 million in 2021, then sank by 74.0% to $591993.0 in 2022, then sank by 90.1% to $58600.0 in 2023, then surged by 2519.53% to $1.5 million in 2024, then jumped by 463.33% to $8.6 million in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $8.6 million, $2.0 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.65 Mn |
| Dec 31, 2025 | 8.65 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 15.04 Mn |
| Sep 30, 2024 | 15.04 Mn |
| Mar 31, 2024 | 2.17 Mn |
| Mar 31, 2024 | 2.17 Mn |
| Dec 31, 2023 | 58,600.00 |
| Dec 31, 2023 | 58,600.00 |
| Sep 30, 2023 | 3.33 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 6.56 Mn |
| Mar 31, 2023 | 6.56 Mn |
| Dec 31, 2022 | 591,993.00 |
| Dec 31, 2022 | 591,993.00 |
| Sep 30, 2022 | 13.17 Mn |
| Sep 30, 2022 | 13.17 Mn |
| Jun 30, 2022 | 2.21 Mn |
| Jun 30, 2022 | 2.21 Mn |
| Mar 31, 2022 | 11.35 Mn |
| Mar 31, 2022 | 11.35 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Sep 30, 2021 | 11.33 Mn |
| Sep 30, 2021 | 11.33 Mn |
| Jun 30, 2021 | 29,167.00 |
| Jun 30, 2021 | 29,167.00 |
| Mar 31, 2021 | 1.31 Mn |
| Mar 31, 2021 | 1.31 Mn |
| Dec 31, 2020 | 11.30 Mn |
| Dec 31, 2020 | 11.30 Mn |
| Sep 30, 2020 | 10.08 Mn |
| Sep 30, 2020 | 10.08 Mn |
| Jun 30, 2020 | 1.70 Mn |
| Jun 30, 2020 | 1.70 Mn |
| Mar 31, 2020 | 9.99 Mn |
| Mar 31, 2020 | 9.99 Mn |
| Dec 31, 2019 | 1,667.00 |
| Dec 31, 2019 | 1,667.00 |
| Sep 30, 2019 | 8.46 Mn |
| Sep 30, 2019 | 8.46 Mn |
| Jun 30, 2019 | 286,050.00 |
| Jun 30, 2019 | 286,050.00 |
| Mar 31, 2019 | 238,966.00 |
| Mar 31, 2019 | 238,966.00 |
| Dec 31, 2018 | 7.20 Mn |
| Dec 31, 2018 | 7.20 Mn |
| Sep 30, 2018 | 6.51 Mn |
| Sep 30, 2018 | 6.51 Mn |
| Jun 30, 2018 | 500,000.00 |
| Jun 30, 2018 | 500,000.00 |
| Mar 31, 2018 | 6.86 Mn |
| Mar 31, 2018 | 6.86 Mn |
| Dec 31, 2017 | 1,500.00 |
| Dec 31, 2017 | 1,500.00 |
| Sep 30, 2017 | 5.09 Mn |
| Sep 30, 2017 | 5.09 Mn |
| Jun 30, 2017 | 5.14 Mn |
| Jun 30, 2017 | 5.14 Mn |
| Mar 31, 2017 | 4.44 Mn |
| Mar 31, 2017 | 4.44 Mn |
| Dec 31, 2016 | 1,500.00 |
| Dec 31, 2016 | 1,500.00 |
| Sep 30, 2016 | 4.20 Mn |
| Sep 30, 2016 | 4.20 Mn |
| Jun 30, 2016 | 75,000.00 |
| Jun 30, 2016 | 75,000.00 |
| Mar 31, 2016 | 50,000.00 |
| Mar 31, 2016 | 50,000.00 |
| Dec 31, 2015 | 2,828.00 |
| Dec 31, 2015 | 2,828.00 |
| Sep 30, 2015 | 1.82 Mn |
| Sep 30, 2015 | 1.82 Mn |
| Dec 31, 2014 | 5,609.00 |
| Dec 31, 2014 | 5,609.00 |
| Sep 30, 2014 | 792,500.00 |
| Sep 30, 2014 | 792,500.00 |
| Sep 30, 2013 | 768,750.00 |
| Sep 30, 2013 | 768,750.00 |